Foundation for Angelman Syndrome Therapeutics

About

The Foundation for Angelman Syndrome Therapeutics (FAST) is a prominent patient advocacy organization focused on finding a cure for Angelman syndrome, a rare neurogenetic disorder that affects about one in 15,000 people globally. FAST is recognized as the largest non-governmental funder of research dedicated to this condition. FAST's mission is to drive research and development programs that improve the lives of individuals with Angelman syndrome. The organization invests in various research initiatives, including gene therapy, reactivation of the UBE3A gene, and symptomatic treatments. In addition to funding research, FAST raises awareness about Angelman syndrome and advocates for the needs of affected individuals and their families. They also provide resources and support to help families navigate the challenges associated with the disorder.